1. Home
  2. KALA vs GORV Comparison

KALA vs GORV Comparison

Compare KALA & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • GORV
  • Stock Information
  • Founded
  • KALA 2009
  • GORV 1976
  • Country
  • KALA United States
  • GORV United States
  • Employees
  • KALA N/A
  • GORV N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • KALA Health Care
  • GORV Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • GORV Nasdaq
  • Market Cap
  • KALA 27.7M
  • GORV 30.7M
  • IPO Year
  • KALA 2017
  • GORV 2015
  • Fundamental
  • Price
  • KALA $5.31
  • GORV $1.37
  • Analyst Decision
  • KALA Strong Buy
  • GORV Hold
  • Analyst Count
  • KALA 2
  • GORV 2
  • Target Price
  • KALA $16.50
  • GORV $2.00
  • AVG Volume (30 Days)
  • KALA 12.6K
  • GORV 46.5K
  • Earning Date
  • KALA 11-11-2024
  • GORV 11-01-2024
  • Dividend Yield
  • KALA N/A
  • GORV N/A
  • EPS Growth
  • KALA N/A
  • GORV N/A
  • EPS
  • KALA N/A
  • GORV N/A
  • Revenue
  • KALA N/A
  • GORV $987,991,000.00
  • Revenue This Year
  • KALA N/A
  • GORV N/A
  • Revenue Next Year
  • KALA N/A
  • GORV $6.13
  • P/E Ratio
  • KALA N/A
  • GORV N/A
  • Revenue Growth
  • KALA N/A
  • GORV N/A
  • 52 Week Low
  • KALA $4.21
  • GORV $1.37
  • 52 Week High
  • KALA $10.97
  • GORV $8.27
  • Technical
  • Relative Strength Index (RSI)
  • KALA 38.22
  • GORV 34.60
  • Support Level
  • KALA $5.25
  • GORV $1.37
  • Resistance Level
  • KALA $5.76
  • GORV $1.44
  • Average True Range (ATR)
  • KALA 0.23
  • GORV 0.07
  • MACD
  • KALA -0.01
  • GORV 0.02
  • Stochastic Oscillator
  • KALA 20.26
  • GORV 0.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: